Stockreport

Korro to Present at the TD Cowen 45th Annual Health Care Conference

Korro Bio, Inc.  (KRRO) 
PDF CAMBRIDGE, Mass., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) (Nasdaq: KRRO), a clinical-stage biopharmaceutical company focused on developing a new clas [Read more]